GNS Healthcare Nets SAIC Contract to Analyze NCI's Drug Interaction Data

The company said that it will use its Reverse Engineering and Forward Simulation platform to build computer models to identify key genetic and molecular mechanisms of drug efficacy and resistance in cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.